• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK SJM TRIFECTA VALVE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/01/2016
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature attachment: article title "thrombocytopenia among patients undergoing aortic valve replacement using the sutureless perceval s bioprosthesis.".
 
Event Description
The article "thrombocytopenia among patients undergoing aortic valve replacement using the sutureless perceval s bioprosthesis" was reviewed.The article presented a restrospective single center study, to compare the incidence, severity, and clinical implications of thrombocytopenia after aortic valve replacement (avr) using the perceval s or the trifecta bioprosthesis.Abbott devices used included the trifecta aortic valve.The article concluded that the perceval s bioprosthesis was associated with more severe postoperative thrombocytopenia.[the primary author and corresponding author was matthias kirschwith corresponding email matthias.Kirsch@chuv.Ch.The time frame of the study was march 2016 to august 2019.A total of 156 patients were included in this study, of which 53 received an abbott device.Comorbidities include previous myocardial infarction, congestive heart failure, diabetes, hypertension, hypercholesterolemia, chronic obstructive pulmonary disease, cerebrovascular arteriopathy, lower extremity arterial disease, previous valve replacement, aortic regurgitation, and bicuspid aortic valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18922978
MDR Text Key337890658
Report Number2135147-2024-01195
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 03/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SJM TRIFECTA VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-